Historical Triumph: Algeria Officially Eradicates Trachoma

The World Health Organization (WHO) has officially validated Algeria for eliminating trachoma as a public health problem. The monumental achievement makes Algeria the 10th country in the WHO African Region and the 29th globally to wipe out the leading infectious cause of blindness, marking a historic victory for the nation’s healthcare system.

A Century-Long Battle Concludes

Trachoma, a bacterial infection that causes severe scarring of the inner eyelid and leads to irreversible blindness if left untreated, was hyperendemic across Algeria for much of the 20th century. Historic data shows that between 1912 and 1955, active infection rates exceeded 90% in multiple regions.

The turning point accelerated significantly following national independence, culminating in the establishment of a free public healthcare system in 1974. This foundation allowed health authorities to launch aggressive, equitable screening and treatment programs that reached deep into the country’s most isolated desert provinces.

The Power of the SAFE Strategy

Algeria’s success relies heavily on its meticulous execution of the WHO-endorsed SAFE strategy, a comprehensive multi-sector blueprint:

• Surgery: Providing corrective operations to treat advanced, blinding stages of the disease (trachomatous trichiasis).
• Antibiotics: Conducting mass distribution campaigns to clear bacterial transmission.
• Facial Cleanliness: Running widespread public education campaigns emphasizing personal hygiene.
• Environmental Improvement: Delivering major infrastructure upgrades to expand water access and sanitation.

By 2022, rigorous nationwide epidemiological surveys confirmed that active trachoma had plummeted below the strict elimination thresholds. To secure the final validation, the Ministry of Health deployed medical teams directly to vulnerable southern communities in 2025, executing door-to-door screenings and achieving an incredible 96% coverage rate.

Sustaining the Health Milestone

Beyond medical interventions, massive long-term investments in municipal utilities proved decisive. Today, over 91% of households in previously endemic zones have direct access to running water, ensuring communities can maintain the hygiene levels required to keep the disease at bay.

With official validation certificates recently presented by WHO Director-General Dr. Tedros Adhanom Ghebreyesus, Algeria shifts its focus to post-validation surveillance. Backed by robust school health systems and widespread specialized eye-care networks, the country is well-positioned to maintain zero transmission and prevent any future resurgence.